356 related articles for article (PubMed ID: 23379486)
1. Hepcidin is a potential regulator of iron status in chronic kidney disease.
Tsuchiya K; Nitta K
Ther Apher Dial; 2013 Feb; 17(1):1-8. PubMed ID: 23379486
[TBL] [Abstract][Full Text] [Related]
2. Hepcidin: clinical utility as a diagnostic tool and therapeutic target.
Coyne DW
Kidney Int; 2011 Aug; 80(3):240-4. PubMed ID: 21677632
[TBL] [Abstract][Full Text] [Related]
3. Hepcidin for clinicians.
Young B; Zaritsky J
Clin J Am Soc Nephrol; 2009 Aug; 4(8):1384-7. PubMed ID: 19556376
[TBL] [Abstract][Full Text] [Related]
4. The role of hepcidin in iron homeostasis and anemia in hemodialysis patients.
Eleftheriadis T; Liakopoulos V; Antoniadi G; Kartsios C; Stefanidis I
Semin Dial; 2009; 22(1):70-7. PubMed ID: 19250447
[TBL] [Abstract][Full Text] [Related]
5. Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study.
Uehata T; Tomosugi N; Shoji T; Sakaguchi Y; Suzuki A; Kaneko T; Okada N; Yamamoto R; Nagasawa Y; Kato K; Isaka Y; Rakugi H; Tsubakihara Y
Nephrol Dial Transplant; 2012 Mar; 27(3):1076-83. PubMed ID: 21799206
[TBL] [Abstract][Full Text] [Related]
6. Serum hepcidin-25 levels predict the progression of renal anemia in patients with non-dialysis chronic kidney disease.
Niihata K; Tomosugi N; Uehata T; Shoji T; Mitsumoto K; Shimizu M; Kawabata H; Sakaguchi Y; Suzuki A; Hayashi T; Okada N; Isaka Y; Rakugi H; Tsubakihara Y
Nephrol Dial Transplant; 2012 Dec; 27(12):4378-85; discussion 4384-5. PubMed ID: 22833619
[TBL] [Abstract][Full Text] [Related]
7. Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia.
Shinzato T; Abe K; Furusu A; Harada T; Shinzato K; Miyazaki M; Kohno S
Med Sci Monit; 2008 Sep; 14(9):CR431-7. PubMed ID: 18758412
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic potential of hepcidin testing in pediatrics.
Cangemi G; Pistorio A; Miano M; Gattorno M; Acquila M; Bicocchi MP; Gastaldi R; Riccardi F; Gatti C; Fioredda F; Calvillo M; Melioli G; Martini A; Dufour C
Eur J Haematol; 2013 Apr; 90(4):323-30. PubMed ID: 23438060
[TBL] [Abstract][Full Text] [Related]
9. [Iron, hepcidin and chronic kidney disease].
Fievet P; Brazier F
Nephrol Ther; 2011 Apr; 7(2):86-91. PubMed ID: 21186144
[TBL] [Abstract][Full Text] [Related]
10. Hepcidin in anemia and inflammation in chronic kidney disease.
Malyszko J; Mysliwiec M
Kidney Blood Press Res; 2007; 30(1):15-30. PubMed ID: 17215586
[TBL] [Abstract][Full Text] [Related]
11. Renal anemia of inflammation: the name is self-explanatory.
Yilmaz MI; Solak Y; Covic A; Goldsmith D; Kanbay M
Blood Purif; 2011; 32(3):220-5. PubMed ID: 21829013
[TBL] [Abstract][Full Text] [Related]
12. Iron metabolism, hepcidin, and anemia in orthotopic heart transplantation recipients treated with mammalian target of rapamycin.
Przybylowski P; Malyszko JS; Macdougall IC; Malyszko J
Transplant Proc; 2013; 45(1):387-90. PubMed ID: 23375326
[TBL] [Abstract][Full Text] [Related]
13. Iron-deficiency anemia secondary to mutations in genes controlling hepcidin.
Cau M; Melis MA; Congiu R; Galanello R
Expert Rev Hematol; 2010 Apr; 3(2):205-16. PubMed ID: 21083463
[TBL] [Abstract][Full Text] [Related]
14. Hepcidin: another culprit for complications in patients with chronic kidney disease?
Nakanishi T; Hasuike Y; Otaki Y; Kida A; Nonoguchi H; Kuragano T
Nephrol Dial Transplant; 2011 Oct; 26(10):3092-100. PubMed ID: 21785039
[TBL] [Abstract][Full Text] [Related]
15. Current status of the measurement of blood hepcidin levels in chronic kidney disease.
Macdougall IC; Malyszko J; Hider RC; Bansal SS
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1681-9. PubMed ID: 20724518
[TBL] [Abstract][Full Text] [Related]
16. Decreased serum hepcidin and improved functional iron status 6 months after restrictive bariatric surgery.
Tussing-Humphreys LM; Nemeth E; Fantuzzi G; Freels S; Holterman AX; Galvani C; Ayloo S; Vitello J; Braunschweig C
Obesity (Silver Spring); 2010 Oct; 18(10):2010-6. PubMed ID: 20075851
[TBL] [Abstract][Full Text] [Related]
17. Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia.
Theurl I; Finkenstedt A; Schroll A; Nairz M; Sonnweber T; Bellmann-Weiler R; Theurl M; Seifert M; Wroblewski VJ; Murphy AT; Witcher D; Zoller H; Weiss G
Br J Haematol; 2010 Feb; 148(3):449-55. PubMed ID: 19863534
[TBL] [Abstract][Full Text] [Related]
18. Is hepcidin-25 a clinically relevant parameter for the iron status in hemodialysis patients?
Brătescu LO; Bârsan L; Munteanu D; Stancu S; Mircescu G
J Ren Nutr; 2010 Sep; 20(5 Suppl):S77-83. PubMed ID: 20797577
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia.
Bârsan L; Stanciu A; Stancu S; Căpuşă C; Brătescu L; Mandache E; Radu E; Mircescu G
Hematology; 2015 Oct; 20(9):543-52. PubMed ID: 25745821
[TBL] [Abstract][Full Text] [Related]
20. Macrophage iron, hepcidin, and atherosclerotic plaque stability.
Sullivan JL
Exp Biol Med (Maywood); 2007 Sep; 232(8):1014-20. PubMed ID: 17720947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
